YONGIN,South Korea,March 13,2025-- GC Cell (KRX:144510),under the leadership of CEO Sungyong Won,announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB‑205),a novel CD

STEQEYMA®,one of the first-wave biosimilars to STELARA®,is now available in the U.S. Approved for the same indications as the reference product,STEQEYMA will be priced with a wholesale acquis

Synergies Between Health Care and Insurance Drive Scalable Growth AI Innovations Fuel Continued Success

BANGKOK,March 11,2025-- Siam Piwat,Thailand\'s leading real estate and retail developer and operator of global destinations Siam Paragon and ICONSIAM,is pioneering a new prototype for world-class luxu

SHANGHAI,March 11,2025-- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE),a leading technology-driven pre-owned consumer electronics transactions and services platform in Chi

Xiong\'an: Area at forefront of reform and opening-up BEIJING,March 11,2025-- A report fromChinadaily.com.cn: